Floatz logo

FLUOROURACILUM

Radiation

China Medical University, ChinaSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Radiation cohort.

Asset / SponsorPhaseRating
Carboplatin
Zhejiang Cancer Hospital
Phase 2CCC
Ivonescimab
Zhejiang Cancer Hospital
Phase 2CCC
Capecitabine
Odense University Hospital
Phase 2CCC
Irinotecan
China Medical University, China
Phase 2CCC
Calcium folinate pentahydrate
China Medical University, China
Phase 2CCC
Eloxatin
China Medical University, China
Phase 2CCC

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →